(Q37642613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

review article

1 reference

title

Mucosal vaccines: recent progress in understanding the natural barriers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Filipa Lebre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Dulce Bento

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Gerrit Borchard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hans E Junginger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

211-223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut.

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-0011-3

Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-0011-3

Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-0011-3

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-0011-3

Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-0011-3

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-0011-3

Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response

21 January 2018

1 reference

12 December 2020

Microparticles as vaccine adjuvants and delivery systems

1 reference

12 December 2020

Man the barrier! Strategic defences in the intestinal mucosa

1 reference

12 December 2020

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles.

1 reference

12 December 2020

Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.

1 reference

12 December 2020

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

1 reference

12 December 2020

Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation

1 reference

12 December 2020

Exploiting M cells for drug and vaccine delivery

1 reference

12 December 2020

A Toll-like receptor recognizes bacterial DNA

1 reference

12 December 2020

Anatomical basis of tolerance and immunity to intestinal antigens

1 reference

12 December 2020

Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres

1 reference

12 December 2020

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

1 reference

12 December 2020

Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node

1 reference

12 December 2020

Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches-deficient mice.

1 reference

12 December 2020

Epithelial cells as sensors for microbial infection

1 reference

12 December 2020

Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase

1 reference

12 December 2020

DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells

1 reference

12 December 2020

Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system

1 reference

12 December 2020

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

1 reference

12 December 2020

A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza.

1 reference

12 December 2020

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

1 reference

12 December 2020

Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention

1 reference

12 December 2020

Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches

1 reference

12 December 2020

Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics

1 reference

12 December 2020

Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2

1 reference

12 December 2020

Expanding dendritic cells in vivo enhances the induction of oral tolerance

1 reference

12 December 2020

Structure and function of the spleen

1 reference

12 December 2020

CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.

1 reference

12 December 2020

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

1 reference

12 December 2020

Immunization against bacterial diseases of the intestine

1 reference

12 December 2020

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

1 reference

12 December 2020

Interactions between commensal intestinal bacteria and the immune system

1 reference

12 December 2020

CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice

1 reference

12 December 2020

The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual

1 reference

12 December 2020

Immunochemistry and polypeptide composition of hepatitis B core antigen (HBc Ag)

1 reference

12 December 2020

Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2

1 reference

12 December 2020

Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin

1 reference

12 December 2020

Nanoparticles and microparticles as vaccine-delivery systems

1 reference

12 December 2020

Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis

1 reference

12 December 2020

Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness

1 reference

12 December 2020

Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.

1 reference

12 December 2020

IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans

1 reference

12 December 2020

Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications

1 reference

12 December 2020

Periscope, up! Monitoring microbes in the intestine.

1 reference

12 December 2020

PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines

1 reference

12 December 2020

The mucosal immune system

1 reference

12 December 2020

ISCOMATRIX adjuvant for antigen delivery

1 reference

12 December 2020

A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice

1 reference

12 December 2020

Development and production aspects of a recombinant yeast-derived hepatitis B vaccine

1 reference

12 December 2020

Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells

1 reference

12 December 2020

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

12 December 2020

A call for replicating vector prime-protein boost strategies in HIV vaccine design

1 reference

12 December 2020

Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.

1 reference

12 December 2020

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

1 reference

12 December 2020

Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12

1 reference

12 December 2020

Immunization without needles

1 reference

12 December 2020

Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa

1 reference

12 December 2020

Mucosal vaccines: the promise and the challenge

1 reference

12 December 2020

Mucosal immunity and vaccines

1 reference

12 December 2020

Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue

1 reference

12 December 2020

Assessment of the protective effect of uncoated alginate microspheres

1 reference

12 December 2020

Japanese encephalitis virus vaccine formulations using PLA lamellar and PLG microparticles

1 reference

12 December 2020

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

12 December 2020

Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2

1 reference

12 December 2020

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries

1 reference

12 December 2020

Immunity in response to particulate antigen-delivery systems

1 reference

12 December 2020

Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches

1 reference

12 December 2020

Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues

1 reference

12 December 2020

ISCOMs and ISCOMATRIX.

1 reference

12 December 2020

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

12 December 2020

Yeast recombinant hepatitis B vaccine

1 reference

12 December 2020

Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems

1 reference

12 December 2020

Pollinex Quattro: a novel and well-tolerated, ultra short-course allergy vaccine

1 reference

12 December 2020

An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles

1 reference

12 December 2020

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

1 reference

12 December 2020

Therapeutic potential of oral tolerance

1 reference

12 December 2020

Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines

1 reference

12 December 2020

Vaccines made from recombinant yeast cells

1 reference

12 December 2020

Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA

1 reference

12 December 2020

Interaction of antigens and antibodies at mucosal surfaces

1 reference

12 December 2020

The role of nasopharyngeal lymphoid tissue

1 reference

12 December 2020

1 reference

12 December 2020

Proteins of hepatitis B surface antigen

1 reference

12 December 2020

Heat stability of a recombinant DNA hepatitis B vaccine

1 reference

12 December 2020

Mast cell activators: a new class of highly effective vaccine adjuvants

1 reference

12 December 2020

NALT- versus Peyer's-patch-mediated mucosal immunity

1 reference

12 December 2020

Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid

1 reference

12 December 2020

PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems

1 reference

12 December 2020

Peripheral nonresponsiveness to orally administered soluble protein antigens

1 reference

12 December 2020

Adjuvant properties of aluminum and calcium compounds.

1 reference

12 December 2020

CpG DNA is an effective oral adjuvant to protein antigens in mice

1 reference

12 December 2020

Starch microparticles as a vaccine adjuvant: only uptake in Peyer's patches decides the profile of the immune response

1 reference

12 December 2020

[The effect of entrapment of CpG sequence with cationic PLG nanoparticles on the immune responses of mice to pig paratyphoid vaccine]

1 reference

12 December 2020

Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction

1 reference

12 December 2020

Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide

1 reference

12 December 2020

Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations

1 reference

12 December 2020

1 reference

12 December 2020

Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future

1 reference

12 December 2020

Proteins of hepatitis B surface antigen: amino acid compositions of the major polypeptides

1 reference

12 December 2020

Recent advances in the discovery and delivery of vaccine adjuvants

1 reference

12 December 2020

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

1 reference

12 December 2020

Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.

1 reference

12 December 2020

Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery

1 reference

12 December 2020

Microparticles for the delivery of DNA vaccines

1 reference

12 December 2020

Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation.

1 reference

12 December 2020

Formation of virosomes from influenza subunits and liposomes

1 reference

12 December 2020

Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants

1 reference

12 December 2020

The IgA system: a comparison of structure and function in different species.

1 reference

12 December 2020

Antigen sampling across epithelial barriers and induction of mucosal immune responses

1 reference

12 December 2020

Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination

1 reference

12 December 2020

Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo

1 reference

12 December 2020

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

1 reference

12 December 2020

Microparticles and polymers for the mucosal delivery of vaccines

1 reference

12 December 2020

Emulsion-based adjuvants for influenza vaccines.

1 reference

12 December 2020

Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice

1 reference

12 December 2020

10.1007/S11095-009-0011-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953309%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference